GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Serina Therapeutics Inc (AMEX:SER) » Definitions » Price-to-Tangible-Book

Serina Therapeutics (Serina Therapeutics) Price-to-Tangible-Book : (As of Jun. 05, 2024)


View and export this data going back to 2024. Start your Free Trial

What is Serina Therapeutics Price-to-Tangible-Book?

As of today (2024-06-05), Serina Therapeutics's share price is $9.35. Serina Therapeutics's Tangible Book per Share of Mar. 2024 for the quarter that ended in Mar. 2024 was $-0.57. Hence, Serina Therapeutics's Price to Tangible Book Ratio of today is .

The historical rank and industry rank for Serina Therapeutics's Price-to-Tangible-Book or its related term are showing as below:

SER's Price-to-Tangible-Book is not ranked *
in the Biotechnology industry.
Industry Median: 2.78
* Ranked among companies with meaningful Price-to-Tangible-Book only.

A closely related ratio is called PB Ratio. As of today, Serina Therapeutics's share price is $9.35. Serina Therapeutics's Book Value per Sharefor the quarter that ended in Mar. 2024 was $-0.50. Hence, Serina Therapeutics's P/B Ratio of today is .


Serina Therapeutics Price-to-Tangible-Book Historical Data

The historical data trend for Serina Therapeutics's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Serina Therapeutics Price-to-Tangible-Book Chart

Serina Therapeutics Annual Data
Trend Dec21 Dec22
Price-to-Tangible-Book
- -

Serina Therapeutics Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Mar24
Price-to-Tangible-Book - - - - -

Competitive Comparison of Serina Therapeutics's Price-to-Tangible-Book

For the Biotechnology subindustry, Serina Therapeutics's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Serina Therapeutics's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Serina Therapeutics's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Serina Therapeutics's Price-to-Tangible-Book falls into.



Serina Therapeutics Price-to-Tangible-Book Calculation

Serina Therapeutics's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Mar. 2024 )
=9.35/-0.57
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Serina Therapeutics Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Serina Therapeutics's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


Serina Therapeutics (Serina Therapeutics) Business Description

Comparable Companies
Traded in Other Exchanges
Address
601 Genome Way, Suite 2001, Huntsville, AL, USA, 35806
Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers.

Serina Therapeutics (Serina Therapeutics) Headlines